References
- Marjanska A, Drogosiewicz M, Demowska-Baginska B, Pawinska-Wasikowska
K, Balwierz W, Bobeff K, Mlynarski W, Mizia-Malarz A, Raciborska A,
Wysocki M, Styczynski J. Nivolumab for the treatment of advanced
pediatric malignancies. Anticancer Research. 2020 (40)12:7095-7100.
- Aldrink JH, Polites SF, Austin M. Pediatric melanoma - diagnosis,
management, and anticipated outcomes. 2021. Sure Once Clin N Am.
2021;373-388.
- Batra S. Spitzoid melanoma of childhood: a case series and review.Future Medicine. 2015; 2(2):121-125.
- Ryan AL et al. Malignant melanoma in children and adolescents treated
in pediatric oncology centers: an Australian and New Zealand
children’s oncology group (ANZCHOG) study. Frontiers in Oncology.
2021;11:1-8.
- Pampena R, Kyrgidis A, Lallas A, Moscarella E, Argenziano G, and
Longo, C. A meta-analysis of nevus-associated melanoma: Prevalence and
practical implications. Journal of the American Academy of
Dermatology. 2017;(77)5: 938 - 945.6.
- Hawryluk EB, Moustafa D, Bartenstein D, Brahmbhatt M., Cordoro K.,
Gardner L., Gauthier A, Grossman D, Gupta D, Hunt RD, Jen M, Kao P,
Kruse LL, Lawley L. P., London, W. B., Mansour, D., O’Haver, J. A.,
Phung, T., Pope, E., Price, H. N., Rogers, T, Shah SD, Wolner Z, Huang
J, Marghoob AA. A retrospective multicenter study of fatal pediatric
melanoma. Journal of the American Academy of Dermatology. 2020;83(5).
- El Sharouni MA, Rawson RV, Potter AJ, Paver EC, Wilmott JS, Witkamp
AJ, Sigurdsson V, van Diest PJ, Scolyer RA, Thompson JF, Lo SN, van
Gils CH. Melanomas in children and adolescents: Clinicopathologic
features and survival outcomes. J Am Acad Dermatol.
2023;88(3):609-616.
- Bartenstein, DW, Kelleher, CM, Friedmann AM, Duncan LM, Tsao H, Sober
A J, Hawryluk EB. Contrasting features of childhood and adolescent
melanomas. Pediatric dermatology. 2018:35 (3), 354-360.
- Moore-Olufemi S, Herzog C, Warneke C, Gershenwald JE, Mansfield P,
Ross M, Prieto V, Lally KP, Hayes-Jordan A. Outcomes in pediatric
melanoma: comparing prepubertal to adolescent pediatric patients. Ann
Surg. 2011;253(6):1211-5
- Pol-Rodriquez M., Lee S., Silvers DN, Celebi JT. Influence of age on
survival in childhood spitzoid melanomas. American Cancer Society.
2007;109(8):1579-1583.
- Davis KL, Fox E, Merchant MS, Reid JM, Kudgus RA, Liu X, Minard CG,
Voss S, Berg SL, Weigel BJ, Mackall CL. Nivolumab in children and
young adults with relapsed or refractory solid tumors or lymphoma
(ADVL1412): a multicentre, open-label, single-arm, phase 1-2 trial.
Lancet Oncol. 2020;21(4):541-550.
- Richards MK, Czechowicz J, Goldin AB, et al. Survival and Surgical
Outcomes for Pediatric Head and Neck Melanoma. JAMA Otolaryngoly Head
Neck Surg. 2017;143(1):34–40.
- Pappo AS, McPherson V, Pan H, Wang F, Wang L, Wright T, Hussong M,
Hawkins D, Kaste SC, Davidoff AM, Bahrami A. A prospective,
comprehensive registry that integrates the molecular analysis of
pediatric and adolescent melanocytic lesions. Cancer.
202;127(20):3825-3831.
- Cordoro KM, Gupta D, Frieden IJ, McCalmont T, Kashani-Sabet M.
Pediatric melanoma: results of a large cohort study and proposal for
modified ABCD detection criteria for children. J Am Acad Dermatol.
2013;68(6):913-25.
- Cymerman RM, Shao Y, Wang K, Zhang Y, Murzaku EC, Penn LA, Osman I,
Polsky D. De Novo vs Nevus-Associated Melanomas: Differences in
Associations With Prognostic Indicators and Survival. J Natl Cancer
Inst. 2016;108(10).
- Lallas A, Kyrgidis A, Ferrara G, Kittler H, Apalla Z, Castagnetti F,
Longo C, Moscarella E, Piana S, Zalaudek I, Argenziano G. Atypical
Spitz tumours and sentinel lymph node biopsy: a systematic review.
Lancet Oncol. 2014;15(4):178-83.